Comparison of efficacy of Diphereline ( IPSEN, France) and Variopeptyl (Varian pharmed, IRAN) in treatment of girls with idiopathic central precocious puberty (CPP)

Phase 2

• Conditions: central precocious puberty.; E22.8

• Registration Number: IRCT20170225032759N1
• Lead Sponsor: Private

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 36

Inclusion Criteria

girls under 8 years, with confirmed central precocious puberty (CPP)
signed Informed Consent Form

Exclusion Criteria

girls older 8 years

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
H. Timepoint: befor intervention then 28 days after injections (days 0-28-56-84). Method of measurement: Cm.;FSH. Timepoint: befor intervention then 28 days after injections (days 0-28-56-84). Method of measurement: Iu/L.;Estradiol. Timepoint: befor intervention then 28 days after injections (days 0-28-56-84). Method of measurement: Iu/L.

Secondary Outcome Measures

Name	Time	Method
Hight. Timepoint: befor intervention then 28 days after injections (days 0-28-56-84). Method of measurement: cm.;Wieght. Timepoint: befor intervention then 28 days after injections (days 0-28-56-84). Method of measurement: Kg.